Sputnik V Firm Says Its COVID-19 Vaccine Cheaper Than Pfizer, Moderna

Modesto Morganelli
Novembre 22, 2020

Last Monday (Nov 16), an EU official involved in the talks said the European Commission wanted to reach a deal with Moderna for the supply of millions of doses of its vaccine candidate for a price below US$25 per dose. "The price of Sputnik V will be much lower", Sputnik V's official account tweeted.

Samples of Sputnik V have already been delivered to India, Hungary, Armenia, Belarus and other countries for ongoing trials.

On 11 August, Russia became the first country in the world to register a coronavirus vaccine, dubbed Sputnik V. The vaccine, which is based on a human adenoviral vector platform, was developed by the Gamaleya Research Institute of Epidemiology and Microbiology and is now completing phase 3 clinical trials. Some experts suggest the data may have been rushed out in an effort to keep up with the worldwide race for a successful coronavirus vaccine.

Hours after the U.S. pharmaceutical giant Moderna said it would charge governments between $25 and $37 per dose for its COVID-19 vaccine candidate, Russian drugmaker Sputnik V claimed that its vaccine would be cheaper than those of Pfizer and Moderna.

A woman holds a small bottle labeled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in front of displayed Pfizer logo in this illustration taken, October 30, 2020.

Just a few weeks earlier, the company, along with collaborator BioNTech, announced that preliminary results from trials showed its potential vaccine was at least 90 percent effective.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE